Virbac
Virbac is a French company dedicated to animal health located in Carros, near Nice. It was founded in 1968 by veterinarian Pierre-Richard Dick.
The company is the 6th the largest veterinarian pharmaceutical group with a turnover of 1,397 million euros in 2024. The company is a limited company with a board Euronext Paris stock exchange - compartiment A and is part of the reference index: SBF 120, and eligible SRD, PEA and PEA-PME.
History
Virbac is a French company dedicated to animal health located in Carros, near Nice. It was founded in 1968 by veterinarian Pierre-Richard Dick. Since his death in 1992, his youngest daughter, Marie-Hélène Dick-Madelpuech, also a veterinary surgeon, has chaired the Board of Directors.In 1985, Virbac was listed on the stock exchange.
In June 2025, Paul Martingell is announced as the new Chief Executive Officer of Virbac, effective September 2025, following the resignation of Sébastien Huron in September 2024. In the meantime, Habib Ramdani serves as interim CEO.
Activities
The company has 6,400 employees and is now present in over 100 countries with 35 sales subsidiaries. Its production is located in 10 countries among which France, the US, Mexico, Brazil, Vietnam. It also has eight research and development centers located in the United States, Mexico, Chile, Uruguay, France, Vietnam, Taiwan and Australia. It generates nearly 60% of its revenues outside France.Its product range is designed to cover the main pathologies in companion animals and livestock: internal and external parasiticides, antibiotics, vaccines, diagnostic tests, dog and cat nutrition, dermatology, dental hygiene, reproductive, aquaculture, anesthesia, geriatrics and electronic identification.